1. Home
  2. NEUP vs BHAT Comparison

NEUP vs BHAT Comparison

Compare NEUP & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • BHAT
  • Stock Information
  • Founded
  • NEUP 1996
  • BHAT 2010
  • Country
  • NEUP United States
  • BHAT China
  • Employees
  • NEUP N/A
  • BHAT N/A
  • Industry
  • NEUP
  • BHAT Recreational Games/Products/Toys
  • Sector
  • NEUP
  • BHAT Consumer Discretionary
  • Exchange
  • NEUP Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • NEUP 12.7M
  • BHAT 12.3M
  • IPO Year
  • NEUP N/A
  • BHAT 2019
  • Fundamental
  • Price
  • NEUP $17.24
  • BHAT $1.68
  • Analyst Decision
  • NEUP Strong Buy
  • BHAT
  • Analyst Count
  • NEUP 2
  • BHAT 0
  • Target Price
  • NEUP $28.00
  • BHAT N/A
  • AVG Volume (30 Days)
  • NEUP 95.7K
  • BHAT 320.2K
  • Earning Date
  • NEUP 11-15-2025
  • BHAT 04-30-2025
  • Dividend Yield
  • NEUP N/A
  • BHAT N/A
  • EPS Growth
  • NEUP N/A
  • BHAT N/A
  • EPS
  • NEUP N/A
  • BHAT N/A
  • Revenue
  • NEUP $15,649,448.00
  • BHAT $18,724,190.00
  • Revenue This Year
  • NEUP N/A
  • BHAT N/A
  • Revenue Next Year
  • NEUP N/A
  • BHAT N/A
  • P/E Ratio
  • NEUP N/A
  • BHAT N/A
  • Revenue Growth
  • NEUP N/A
  • BHAT N/A
  • 52 Week Low
  • NEUP $2.90
  • BHAT $1.51
  • 52 Week High
  • NEUP $126.00
  • BHAT $35.00
  • Technical
  • Relative Strength Index (RSI)
  • NEUP 60.56
  • BHAT 43.43
  • Support Level
  • NEUP $14.64
  • BHAT $1.66
  • Resistance Level
  • NEUP $19.21
  • BHAT $1.85
  • Average True Range (ATR)
  • NEUP 2.14
  • BHAT 0.14
  • MACD
  • NEUP -0.03
  • BHAT -0.02
  • Stochastic Oscillator
  • NEUP 59.46
  • BHAT 10.00

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

Share on Social Networks: